New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
In the drive to deprescribe, heartburn drug study teaches key lessons

In the drive to deprescribe, heartburn drug study teaches key lessons

byUniversity of MichiganCredit: Pixabay/CC0 Public DomainWhether it's costs, safety risks, or "pill fatigue" they're trying to reduce, many health systems and clinics have star
Breakthroughs April 28,2024
In the drive to deprescribe, heartburn drug study teaches key lessons

In the drive to deprescribe, heartburn drug study teaches key lessons

byUniversity of MichiganCredit: Pixabay/CC0 Public DomainWhether it's costs, safety risks, or "pill fatigue" they're trying to reduce, many health systems and clinics have star
Breakthroughs April 28,2024
Popular diabetes drugs do not increase thyroid cancer risk, study suggests

Popular diabetes drugs do not increase thyroid cancer risk, study suggests

byKarolinska InstitutetCredit: CC0 Public DomainDrugs known as GLP-1 analogs have become increasingly popular to treat diabetes and obesity, but there have been concerns that they might increase
Breakthroughs April 28,2024
Popular diabetes drugs do not increase thyroid cancer risk, study suggests

Popular diabetes drugs do not increase thyroid cancer risk, study suggests

byKarolinska InstitutetCredit: CC0 Public DomainDrugs known as GLP-1 analogs have become increasingly popular to treat diabetes and obesity, but there have been concerns that they might increase
Breakthroughs April 28,2024
AACR: Cadonilimab plus chemo beneficial for gastric adenocarcinoma

AACR: Cadonilimab plus chemo beneficial for gastric adenocarcinoma

by Elana GotkineFor patients with gastric/gastroesophageal junction (G/GEJ) adenocarcinoma, cadonilimab plus chemotherapy is associated with improved overall survival and progression-free survival, ac
Oncology April 28,2024
AACR: Cadonilimab plus chemo beneficial for gastric adenocarcinoma

AACR: Cadonilimab plus chemo beneficial for gastric adenocarcinoma

by Elana GotkineFor patients with gastric/gastroesophageal junction (G/GEJ) adenocarcinoma, cadonilimab plus chemotherapy is associated with improved overall survival and progression-free survival, ac
Oncology April 28,2024
Chelation therapy does not improve outcomes after heart attack

Chelation therapy does not improve outcomes after heart attack

byAmerican College of CardiologyCredit: Pixabay/CC0 Public DomainPeople with diabetes who had suffered a heart attack derived no clinical benefit from edetate disodium-based chelation, a therapy
Breakthroughs April 28,2024
Chelation therapy does not improve outcomes after heart attack

Chelation therapy does not improve outcomes after heart attack

byAmerican College of CardiologyCredit: Pixabay/CC0 Public DomainPeople with diabetes who had suffered a heart attack derived no clinical benefit from edetate disodium-based chelation, a therapy
Breakthroughs April 28,2024
Topical tranexamic acid found inferior to intravenous administration

Topical tranexamic acid found inferior to intravenous administration

byAmerican College of CardiologyCredit: Pixabay/CC0 Public DomainAdministering tranexamic acid (TxA), a drug used to reduce bleeding during heart surgery topically rather than intravenously did
Breakthroughs April 28,2024
Topical tranexamic acid found inferior to intravenous administration

Topical tranexamic acid found inferior to intravenous administration

byAmerican College of CardiologyCredit: Pixabay/CC0 Public DomainAdministering tranexamic acid (TxA), a drug used to reduce bleeding during heart surgery topically rather than intravenously did
Breakthroughs April 28,2024
FDA approves new antibiotic for three indications

FDA approves new antibiotic for three indications

by Lori SolomonThe U.S. Food and Drug Administration has approved the antibiotic Zevtera (ceftobiprole medocaril sodium for injection) for three different indications, including treatment of adults wi
Breakthroughs April 28,2024
FDA approves new antibiotic for three indications

FDA approves new antibiotic for three indications

by Lori SolomonThe U.S. Food and Drug Administration has approved the antibiotic Zevtera (ceftobiprole medocaril sodium for injection) for three different indications, including treatment of adults wi
Breakthroughs April 28,2024
Study identifies factors that affect antibiotic prescribing for acne

Study identifies factors that affect antibiotic prescribing for acne

by Elana GotkineMultiple salient factors affect long-term antibiotic prescribing practices for acne, according to a studypublishedinJAMA Dermatology.Ronnie A. Festok, from the Emory
Breakthroughs April 28,2024
Study identifies factors that affect antibiotic prescribing for acne

Study identifies factors that affect antibiotic prescribing for acne

by Elana GotkineMultiple salient factors affect long-term antibiotic prescribing practices for acne, according to a studypublishedinJAMA Dermatology.Ronnie A. Festok, from the Emory
Breakthroughs April 28,2024
Migraine sufferers in England may soon be able to access a preventative drug: Atogepant

Migraine sufferers in England may soon be able to access a preventative drug: Atogepant

by Anna Andreou,The ConversationCredit: Unsplash/CC0 Public DomainA drug that can help prevent migraines could soon be available on the NHS. Atogepant (brand name: Aquipta) was recently recommen
Breakthroughs April 28,2024
Migraine sufferers in England may soon be able to access a preventative drug: Atogepant

Migraine sufferers in England may soon be able to access a preventative drug: Atogepant

by Anna Andreou,The ConversationCredit: Unsplash/CC0 Public DomainA drug that can help prevent migraines could soon be available on the NHS. Atogepant (brand name: Aquipta) was recently recommen
Breakthroughs April 28,2024
Study shows web app effective in determining access to statins without a prescription

Study shows web app effective in determining access to statins without a prescription

byAmerican College of CardiologyCredit: Pixabay/CC0 Public DomainUsing a web application to qualify individuals for treatment with a non-prescription statin closely matched the results of clinic
Breakthroughs April 28,2024
Study shows web app effective in determining access to statins without a prescription

Study shows web app effective in determining access to statins without a prescription

byAmerican College of CardiologyCredit: Pixabay/CC0 Public DomainUsing a web application to qualify individuals for treatment with a non-prescription statin closely matched the results of clinic
Breakthroughs April 28,2024
Optimal timing maximizes Paxlovid benefits for treating COVID-19

Optimal timing maximizes Paxlovid benefits for treating COVID-19

byeLifeCredit: CC0 Public DomainResearchers have described the optimal timing for COVID-19 patients to take the antiviral, Paxlovid, to get the most benefit from the treatment, according to a st
Breakthroughs April 28,2024
Optimal timing maximizes Paxlovid benefits for treating COVID-19

Optimal timing maximizes Paxlovid benefits for treating COVID-19

byeLifeCredit: CC0 Public DomainResearchers have described the optimal timing for COVID-19 patients to take the antiviral, Paxlovid, to get the most benefit from the treatment, according to a st
Breakthroughs April 28,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com